Table 3. Follow-up indicators for the implementation of the guidelines.
| Type of indicator | Name of indicator | Operational formulation | Frequency | Primary source | Goal |
|---|---|---|---|---|---|
| structural | Percentage of laboratories that measure HbA1c in the manner recommended by the NGSPP (www.ngsp.org). | Number of laboratories measuring HbA1c in the manner recommended by the NGSPP / Number of laboratories measuring HbA1c × 100 | Annual | EPS | First year: 50%, Second year: 100% |
| Process | Percentage of patients with T2DM (Code CIE-10: E11) who undergo at least two HbA1c measurements per year | (Number of patients with a clinical diagnosis of T2DM [Code CIE10: E11] who undergo at least two HbA1c measurements per year) / (Number of patients with a clinical diagnosis of T2DM (Code CIE10: E11)) * 100 | Annual | IPS | First year: 60% Second year: 90% |
| Percentage of patients with T2DM (Code CIE10: E11) who undergo an annual urinary albumin excretion rate (UAER) test | (Number of patients with a clinical diagnosis of T2DM (Code CIE10: E11) who undergo an UAER test during the year) / (Total number of patients with a clinical diagnosis of T2DM (Code CIE10: E11)) * 100 | Annual | IPS | Primer año: 50%. Tercer año: 90% | |
| Resultado | Percentage of patients with T2DM [Code CIE10: E11] with glycosylated hemoglobin (HbA1c) levels less than or equal to 7% | (Number of patients with a clinical diagnosis of T2DM (Code CIE10: E11) with HbA1c values ≤7%) / (Total number of patients with a clinical diagnosis of T2DM (Code CIE10: E11)) * 100 | Every 6 months | IPS | First year: 40% Second year: 70% |
EPS= Health Promotion Organizations, IPS= Health Provider Institutions